Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds
Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, 8000 El Rio, Houston, TX 77054, USA
BMC Pharmacology 2008, 8:12 doi:10.1186/1471-2210-8-12Published: 13 June 2008
Additional File 1:
Supplemental Tables. Three additional tables that summarize data sets and results.
Format: DOC Size: 35KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional File 2:
Oral clearance and bioavailability values. A table of oral clearance and bioavailability values used in the manuscript.
Format: PDF Size: 144KB Download file
This file can be viewed with: Adobe Acrobat Reader